Our Scientific Advisory Board for CRELD1

top of page

Scientific Advisory Board

We are blessed to be guided by a brilliant and devoted team of gene, rare disease and neurology experts. Each of them shares our commitment to advancing the understanding of CRELD1-related disorder and improving the lives of children born with this rare genetic disorder.

Kirsty McWalter

Research Program Manager, GeneDx

Dr. David McCormick

Consultant Paediatrician, King's College Hospital

Dr. Charles Steward

Patient advocate and genome scientist

dr. Natalie trump

Clinical Scientist, Congenica

professor Nick Lench

Executive Director, MRC/UKRI Nucleic Acid Therapy Accelerator (NATA)

professor Howard Goodkin

chief of paediatric neurology, University of Virginia (UVA)

Dr. Lauren Jeffries

Associate Research Scientist in Pediatrics (Critical Care Medicine), yale school of medicine

Dr. Saquib Lakhani

Associate Professor Term; Clinical Director, Pediatric Genomics Discovery Program, yale school of medicine

Dr. Jonathan M. Mudge

project leader, European Bioinformatics Institute, European Molecular Biology Laboratory

Dr. felix chan

Assistant Professor in Pharmacology, university of birmingham

Dr. lissette sanchez-aranguren

Lecturer in Cellular Bioenergetics, aston university

Dr. Marlen Lauffer

Senior Researcher, Dutch Center for RNA Therapeutics, Institute of Human Genetics,

Leiden University Medical Center

bottom of page